VA Disability Rating for Benign Brain Tumors (DC 8003)
Diagnostic Code 8003 · 38 CFR §4.124a
What Is It?
DC 8003 is the benign half of the schedule's "Brain, new growth of" entry — meningiomas, acoustic neuromas (vestibular schwannomas), pituitary adenomas, and other non-cancerous growths inside the skull. Benign does not mean harmless: a tumor in a fixed bony space presses on whatever is next to it, so depending on location it can cause headache, seizures, vision loss, hearing loss and imbalance, hormonal failure, or focal weakness, and surgery or radiation to remove it carries its own neurological cost. Service connection can run through radiation exposure, other toxic exposure, or head trauma; 38 CFR §3.309(a) also lists "Tumors, malignant, or of the brain or spinal cord or peripheral nerves" among the chronic diseases — the phrasing reaches tumors of the brain whether or not they are malignant — presumed service-connected under §3.307(a)(3) when manifest to a degree of 10 percent or more within one year of separation. 38 CFR §4.124a opens the neurological schedule with a bracketed instruction: disability from the diseases it lists "may be rated from 10 percent to 100 percent in proportion to the impairment of motor, sensory, or mental function," referring the rater to the appropriate body system of the schedule for each manifestation. Inside the 8000–8025 block the schedule prints either a single flat percentage, a single minimum rating, or no percentage at all — there is no severity ladder anywhere in it. A Note closing the block adds two conditions: the minimum ratings for residuals require ascertainable residuals, and when a rating above the minimum is assigned, the diagnostic codes used as the basis of that evaluation must be cited alongside the code identifying the diagnosis. DC 8003 prints two figures and no ladder: "Benign, minimum — 60," and then "Rate residuals, minimum — 10." The 60 is a floor for the tumor itself, not a tier, and it is a good deal higher than most veterans expect.
Rating Criteria
| Rating | Criteria |
|---|---|
| 60% | Benign new growth of the brain, minimum rating. This is the floor the schedule sets for the tumor itself — the entry reads "Benign, minimum — 60." It is not a middle tier, and there is no rung below it while the tumor is the ratable entity. §4.124a's preamble and §4.120 both govern what happens above the floor: disability in this field is rated in proportion to the impairment of motor, sensory, or mental function, with partial loss of use of one or more extremities from a neurological lesion rated by comparison with the mild, moderate, severe, or complete paralysis of the relevant peripheral nerves. The Note closing the 8000–8025 block requires ascertainable residuals for the minimum and requires that any rating above it cite the diagnostic codes used as its basis. |
| 10% | Rate residuals, minimum. Once the tumor is treated and the evaluation moves to what it left behind, the schedule sets a floor of 10 percent on those residuals, each rated under the code for the function it impairs — hearing loss, visual impairment, endocrine failure, seizures, or a cranial nerve deficit. The Note closing the 8000-8025 block requires the residuals to be ascertainable and requires any rating above the minimum to cite the codes it was built from. |
Evidence Needed
Brain MRI showing the tumor, its precise location, and its size is the central study, with serial imaging documenting growth or stability; pathology if a biopsy or resection was done. Because the percentage above each floor is built from the specific residuals, the evidence that moves it is targeted: audiometry for an acoustic neuroma, formal visual field testing for anything near the optic apparatus, a full endocrine panel for a pituitary adenoma, EEG and a seizure log if seizures developed, and neuropsychological testing for cognitive change. Surgical and radiation records document the treatment and its own consequences. For the presumptive route, the diagnosis date against the separation date; for direct connection, the exposure or trauma documentation and a medical opinion.
C&P Exam Tips
Bring serial MRI reports so the examiner can see the tumor and any change over time, plus the objective testing for each affected system — audiogram, visual fields, hormone panel. Describe every symptom the tumor causes rather than only the most obvious one, and be specific: which ear and how much hearing is gone, where the visual field defect sits, what the hormone deficiency requires you to take. Report any seizures with type and frequency. If the tumor has been removed, describe what changed and what did not, including surgical complications. Ask that each deficit be recorded separately under its own code, because the decision has to cite those codes for any evaluation above the minimum.
How to File
File VA Form 21-526EZ claiming a benign brain tumor under DC 8003 and cite 38 CFR §4.124a. Attach the imaging, pathology if any, and treatment records, and claim each residual by name as well — hearing loss, visual field loss, endocrine deficiency, seizures — with the objective testing for each, since that is what the decision must cite for anything above the minimum. Surgery is not a prerequisite: a tumor being monitored rather than treated is still ratable. If the tumor became compensably disabling within a year of separation, cite 38 CFR §3.309(a) and §3.307(a)(3); otherwise document the radiation, toxic exposure, or head trauma the claim runs through.
Common Mistakes
Assuming benign means a low rating. The schedule sets a 60 percent minimum for the tumor itself. Reading the 10 percent as the bottom of a ladder rather than as the floor for residuals after treatment. Claiming the tumor and leaving the hearing loss, visual field defect, or hormone deficiency undocumented, so there is nothing for the rater to build with. Skipping the objective testing each of those residuals needs. Waiting until the tumor grows before filing.
Frequently Asked Questions
Is the minimum for a benign brain tumor really 60 percent?
Yes, while the tumor itself is the ratable entity. 38 CFR §4.124a prints the entry as "8003 Benign, minimum — 60," followed by "Rate residuals, minimum — 10." The 60 is a floor, not a middle step, and the schedule prints nothing between it and 100. Once treatment is finished and the evaluation moves to residuals, the applicable floor becomes the 10 percent one, with the actual percentage built in proportion to impairment under the codes for the specific residuals.
Do I need surgery to be rated for a benign brain tumor?
No. Nothing in DC 8003 conditions the evaluation on surgical removal. A tumor under active surveillance is still a tumor, and the code reaches it. What the claim needs is imaging establishing the diagnosis and evidence of the impairment it causes. If the tumor is genuinely asymptomatic, establishing service connection now still matters, because it protects the effective date if the tumor grows or produces deficits later.
Can I get separate ratings for the hearing loss or hormone problems?
That is exactly how the block is built. §4.124a's preamble directs the rater to the appropriate body system of the schedule for each manifestation, and the Note closing the 8000-8025 block requires that the codes used as the basis of evaluation be cited whenever a rating exceeds the prescribed minimum. So hearing loss is evaluated under §4.85, visual impairment under §4.79, an endocrine deficiency under §4.119, and so on. Whether those are combined or subsumed depends on the facts, but each one needs to be documented in its own terms to be counted at all.